Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner

Seitaro OdaDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, JapanCorrespondence[email protected]

http://orcid.org/0000-0003-4101-5113

Takeshi NakauraDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Daisuke UtsunomiyaDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Kyoko HirakawaDepartment of Cardiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Seiji TakashioDepartment of Cardiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Yasuhiro IzumiyaDepartment of Cardiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Kenichi TsujitaDepartment of Cardiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Hiroyuki HataDepartment of Informative Clinical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Yukio AndoDepartment of Neurology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Yasuyuki YamashitaDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

show all

References

Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54.
PubMed Web of Science ®Google Scholar
Fontana M, Pica S, Reant P, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570–1579.
PubMed Web of Science ®Google Scholar
Fontana M, Banypersad SM, Treibel TA, et al. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology. 2015;277:388–397.
PubMed Web of Science ®Google Scholar
Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J. 2015;36:244–251.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date